{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.3:c.150G>A",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "G",
            "alt": "A",
            "position": "150"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "E",
            "position": "50"
          },
          "Description in input context": "A missense mutation in the SNCA gene (c.150G>A, p.G50E) associated with Parkinson's disease."
        },
        {
          "HGVS": "NM_000340.3:c.207G>A",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "G",
            "alt": "A",
            "position": "207"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "E",
            "position": "69"
          },
          "Description in input context": "Another missense mutation in the SNCA gene (c.207G>A, p.G69E) linked to Lewy body dementia."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005232"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Postmortem brain tissue from Parkinson's disease patients",
        "Description": "Immunohistochemistry was performed on postmortem brain tissue from Parkinson's disease patients and healthy controls."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.150G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased α-synuclein aggregation was observed in brain tissue with the c.150G>A variant compared to controls."
        },
        {
          "Variant": "NM_000340.3:c.207G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Enhanced α-synuclein oligomerization was detected in brain tissue with the c.207G>A variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five biological replicates were analyzed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "No technical replicates were mentioned in the study."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein-expressing cells were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-transfected cells were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used to compare mutant and control groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "α-synuclein oligomerization levels below 10% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "α-synuclein oligomerization levels exceeding 30% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}